Integrated proteomics and metabolomics analysis of cardiac-tissue in mice with sepsis

Heyu Ji,Ting Xiao,Peijun Li,Fei Yu,Rong Yu,Fengling Yu,Xinyu Ma,Junmei Xu,Yulong Cui
DOI: https://doi.org/10.21203/rs.3.rs-2194702/v1
2022-01-01
Abstract:Abstract Introduction: Sepsis remains a devastating disease with a high fatality rate in most nations. Heart failure accounts for around half of all deaths in sepsis patients. Because of the peculiarities of cardiac tissue, the specific mechanism of sepsis-induced cardiac dysfunction remains largely unknown. Objectives: The goal of this study was to develop a more complete understanding of the molecular pathways of septic cardiomyopathy by doing an integrated proteome and metabolomics analysis on a sepsis-infected mouse model. Methods: The CLP mice were utilized as a model in this study to investigate the impact of septic cardiomyopathy on the molecular changes in heart tissues through combining metabolomics and proteomics studies. Results: The present findings suggest that 118 proteins (75-upregulated and 43-downregulated) and 138 metabolites (124-upregulated and 14-downregulated) were significantly altered. Additionally, these compounds play a significant role in biological processes, such as platelet activation, mineral absorption, drug metabolism, terpenoid backbone biosynthesis, and butanoate metabolism. The comprehensive analysis discovered that prostaglandin H2, prostaglandin I2, thromboxane A2, and L-Glutamine might play essential roles in combating sepsis-induced heart dysfunction. Conclusions: Overall, this work adds to our understanding of the implications of sepsis-induced cardiac dysfunction and may lead to identifying novel potential biomarkers and a better understanding of sepsis pathophysiology.
What problem does this paper attempt to address?